Results: A significantly higher expression of N-cadherin was observed in SCC compared to BCC, with 14% of SCC cases having a more than 50% expression of N-cadherin, and 10% with 26–50% expression, in comparison with 2.7% and 8.2% in BCC, respectively (p < 0.001). Here, CDH2 is linked to skin basal cell carcinoma.